Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Richard Wenkart currently holds 200,000 shares of Targeted Medical Pharma, Inc. (TRGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Richard Wenkart has been a net neutral trader of TRGM stock. They have purchased $0 and sold $0 worth of shares.
Thomas Richard Wenkart's most recent insider trade was on Mar 4, 2016, when they sold 200,000 shares at $0.05 per share.
Thomas Richard Wenkart serves as Executive at Targeted Medical Pharma, Inc. (TRGM). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Thomas Richard Wenkart holds the position of Executive at Targeted Medical Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Thomas Richard Wenkart has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Thomas Richard Wenkart was on Dec 31, 2015, when they purchased $13.2K worth of TRGM shares. This transaction involved 44,058 shares at $0.30 per share.
Thomas Richard Wenkart currently owns 200,000 shares of Targeted Medical Pharma, Inc. (TRGM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Richard Wenkart's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Richard Wenkart has 3 Form 4 filings on record as an insider at Targeted Medical Pharma, Inc..
Set alerts for Thomas Richard Wenkart and 40,000+ other insiders.